Sagility India Limited (MAINBOARD)
Nov 5, 2024 - Nov 7, 2024
| Price | ₹28 - ₹30 |
| Premium | ₹0.3 |
|---|---|
| Lot size | 500 |
| Allotment | Nov 9, 2024 |
| Listing | Nov 12, 2024 |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 500 | 15000 | 140060 |
| sHNI | 14 | 7000 | 210000 | 5002 |
| bHNI | 67 | 33500 | 1005000 | 10004 |
Last updated on 07-Nov-2024 18:43:03
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 210089779 | 738682000 | 3.52 |
| HNIs | 105044889 | 202702500 | 1.93 |
| HNIs 10+ | 70029926 | 118450500 | 1.69 |
| HNIs 2+ | 35014963 | 84252000 | 2.41 |
| Retail | 70029926 | 291502500 | 4.16 |
| Employees | 1900000 | 7130000 | 3.75 |
| Total | 387064594 | 1240017000 | 3.2 |
Application-Wise Breakup (Approx. no. of Apps) | |||
|---|---|---|---|
| Category | Reserved | Applied | Times |
| HNIs (10L+) | 10004 | 2846 | 0.28 |
| HNIs (2-10L) | 5002 | 11285 | 2.26 |
| Retail | 140060 | 549274 | 3.92 |
| Employee | - | 10530 | - |
| Total Applications: 573935 | |||
| © IPO Premium | |||
| Subscription Demand (in ₹ crore) | |||
|---|---|---|---|
| Category | Offered | Demand | Times |
| QIBs | 630.27 | 2216.05 | 3.52 |
| FIIs | - | 1874.4 | - |
| DIIs | - | 95.3 | - |
| Mutual funds | - | 178.5 | - |
| Others | - | 67.84 | - |
| HNIs | 315.13 | 608.11 | 1.93 |
| HNIs 10+ | 210.09 | 355.35 | 1.69 |
| HNIs 2+ | 105.04 | 252.76 | 2.41 |
| Retail | 210.09 | 874.51 | 4.16 |
| Employees | 5.7 | 21.39 | 3.75 |
| Total | 1161.19 | 3720.05 | 3.2 |
| QIB Interest Cost per share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹0.14 | @8% ₹0.16 | @9% ₹0.18 | @10% ₹0.2 | @11% ₹0.22 | @12% ₹0.24 |
Sagility India IPO Details
| Issue Size | 702,199,262 shares (aggregating up to ₹2,106.60 Cr) |
| Offer for Sale | 702,199,262 shares of ₹10 (aggregating up to ₹2,106.60 Cr) |
| Employee Discount | Rs 2 per share |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 4,681,328,413 |
| Share holding post issue | 4,681,328,413 |
Sagility India IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not less than 75.00% of the Net offer |
| Retail Shares Offered | Not more than 10.00% of the Net Offer |
| NII (HNI) Shares Offered | Not more than 15.00% of the Net Issue |
Key Performance Indicator
| KPI | Jun-24 | Mar-24 | Mar-23 |
|---|---|---|---|
| RONW | 0.29% | 3.54% | 2.31% |
| D/E | 0.15 | 0.34 | 0.37 |
| EPS (basic) | 0.05 | 0.53 | 0.33 |
| P/E Pre IPO | 61.52 | ||
| P/E Post IPO | 61.52 |
Company Financials
Sagility India Limited Financial Information (Restated Consolidated)
| Period | Jun 2024 | Mar 2024 | Mar 2023 | Mar 2022 | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 10,388.01 | 10,664.2 | 10,590.48 | 10,096.28 | ||||||||||||||||||||||||||||||||||||
| Revenue | 1,247.76 | 4,781.5 | 4,236.06 | 944.39 | ||||||||||||||||||||||||||||||||||||
| Profit | 22.29 | 228.27 | 143.57 | -4.67 | ||||||||||||||||||||||||||||||||||||
| Net Worth | 7,608.16 | 6,443.13 | 6,206.67 | 4,026.62 | ||||||||||||||||||||||||||||||||||||
| Reserves | 2,704.28 | 1,855.44 | 4,013.38 | 2,073.8 | ||||||||||||||||||||||||||||||||||||
| Borrowing | 943.91 | 1,933.52 | 2,347.94 | 4,239.23 | ||||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
About Company
Sagility India Limited, previously known as Berkmeer India Private Limited, specializes in healthcare-oriented solutions for Payers (U.S. health insurers covering healthcare costs) and Providers (hospitals, physicians, diagnostics, and medical technology companies). The company’s services for payers cover a comprehensive range of operational needs, from centralized claims administration to clinical management, addressing claims processing, payment accuracy, and clinical services. For providers, Sagility offers revenue cycle management to streamline billing and treatment cost claims. Additionally, some payer services extend to Pharmacy Benefit Managers (PBMs), assisting them with prescription drug coverage management for health plan members. Serving exclusively U.S.-based customers, Sagility’s five largest customer groups have an average tenure of 17 years as of March 31, 2024, and in January 2024, it supported five of the top ten U.S. payers (as per the Everest Report). The company added 20 new clients across fiscal years 2023 and 2024. Employing 35,044 people as of March 31, 2024, with 60.52% women, the team includes 1,687 certified professionals—374 medical coders, 1,280 registered nurses across the U.S., Philippines, and India, and 33 employees holding degrees in dentistry, surgery, and pharmacy.
ICICI Securities Limited
ifl Securities Ltd
Jefferies India Private Limited
J.P. Morgan India Private Limited
Leadership in U.S. Payer and Provider Market: Sagility has a strong position in the large U.S. healthcare services market, leveraging industry growth, outsourcing trends, and the essential nature of its services to drive long-term business growth.
Healthcare Domain Expertise: With over 24 years in the industry, Sagility provides specialized, technology-enabled services for both Payers and Providers, building extensive expertise across healthcare operations.
Scalable, Technology-Driven Solutions: Sagility offers a range of proprietary tools and platforms, utilizing RPA, analytics, and AI, to support end-to-end services for Payers and revenue cycle management for Providers.
High Industry Competition: The healthcare services sector is highly competitive, and failure to maintain an edge may impact Sagility's business and financial results.
Dependence on U.S. Healthcare Market: Sagility's sole focus on the U.S. healthcare industry exposes it to risks from market-specific changes, such as slowed growth or reduced outsourcing.
Goodwill and Intangible Asset Risks: Goodwill and intangible assets form a major part of Sagility's assets; any impairment could harm its reputation and financial stability.
Phone: +91-22-4918 6270
Email: sagility.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html